Clinical Trials
4
Active:0
Completed:2
Trial Phases
2 Phases
Phase 1:1
Not Applicable:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)β’ Click on a phase to view related trials
Not Applicable
3 (75.0%)Phase 1
1 (25.0%)A Study Evaluating the Efficacy of the Vielight Neuro RX Gamma in the Treatment of Post COVID-19 Cognitive Impairment
Phase 1
Completed
- Conditions
- Post COVID-19 Cognitive Impairment
- First Posted Date
- 2023-05-12
- Last Posted Date
- 2025-06-15
- Lead Sponsor
- Vielight Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT05857124
- Locations
- πΊπΈ
Ascada Research, Fullerton, California, United States
Vielight RX Plus for the Treatment of COVID-19 Respiratory Symptoms
Not Applicable
- Conditions
- COVID-19
- First Posted Date
- 2020-06-05
- Last Posted Date
- 2021-06-14
- Lead Sponsor
- Vielight Inc.
- Target Recruit Count
- 295
- Registration Number
- NCT04418505
- Locations
- πΊπΈ
Progressive Medical Research, Port Orange, Florida, United States
π¨π¦Dr. Michael Zahavi, Oshawa, Ontario, Canada
Neuro RX Gamma - Pivotal Phase
Not Applicable
Suspended
- Conditions
- Alzheimer Disease
- First Posted Date
- 2018-03-30
- Last Posted Date
- 2023-01-25
- Lead Sponsor
- Vielight Inc.
- Target Recruit Count
- 228
- Registration Number
- NCT03484143
- Locations
- πΊπΈ
Headlands Research Orlando, Orlando, Florida, United States
π¨π¦Okanagan Clinical Trials, Kelowna, British Columbia, Canada
π¨π¦Healthtech Connex /Fraser Health, Surrey, British Columbia, Canada
Vielight Neuro RX Gamma - Feasibility Pilot
Not Applicable
Completed
- Conditions
- Alzheimer Disease
- First Posted Date
- 2017-11-01
- Last Posted Date
- 2023-01-25
- Lead Sponsor
- Vielight Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT03328195
- Locations
- π¨π¦
Toronto Memory Program, Toronto, Ontario, Canada
News
No news found